This page is currently under construction. For orders, please visit https://shop.aushealth.com.au/
or return to Aushealth homepage.
AusHealth
Home / Research / Apomab

APOMAB®

A ground-breaking cancer treatment and diagnostics tool, developed at the Royal Adelaide Hospital in South Australia.

After years of research at RAH exploring the unique mechanism and potential of APOMAB to diagnose and treat cancer in preclinical models, it is highly pleasing to see this technology demonstrate targeted delivery of radiation to tumours in clinical settings.

Professor Michael Brown
APOMAB

Our early research demonstrated that APOMAB binds cancer cells after cytotoxic anticancer treatment. It’s brilliant to see the same binding effect taking place in APOMAB-dosed cancer patients.

Managing Director and CEO Greg Johansen
AusHealth
Hit enter to search or ESC to close